Stay clear of coadministration with sensitive CYP3A substrates. If coadministration unavoidable, observe for adverse reactions and minimize CYP3A substrate dose in accordance with product or service labeling.bosentan will reduce the extent or impact of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.The effects